Featured Research

from universities, journals, and other organizations

New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors

Date:
August 4, 2010
Source:
University of California - Los Angeles
Summary:
Given the clinical need for improved in vitro molecular diagnostic technologies for brain tumor biopsies, the research team combined the advantages of microfluidics and microscopy-based cell imaging to develop the microfluidic image cytometry platform. The new platform provides multiparameter, single-cell signaling measurements (fingerprints) of brain tumor samples. The ability to measure these molecular fingerprints on small samples marks a new advance in molecular diagnostics that will enable predictive and personalized medicine.

The microfluidic imaging cytometry (MIC) platform incorporates microfluidic manipulation and imaging of tumor biopsies with bioinformatic analysis. The single cell-based tumor characterization provided is being developed for a systems pathology approach to tumor diagnostics and personalized medicine.
Credit: Image courtesy of University of California - Los Angeles

New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.

Researchers at UCLA have now developed a microfluidic image cytometry (MIC) platform that can measure cell-signaling pathways in brain tumor samples at the single-cell level. The new technology combines the advantages of microfluidics and microscopy-based cell imaging.

The ability to make these in vitro molecular measurements, or "fingerprints," marks a new advance in molecular diagnostics that could ultimately help physicians predict patient prognosis and guide personalized treatment.

"The MIC is essentially a cancer diagnostic chip that can generate single-cell 'molecular fingerprints' for a small quantity of pathology samples, including brain tumor tissues," said Dr. Hsian-Rong Tseng, a UCLA associate professor of molecular and medical pharmacology and one of the leaders of the research. "We are exploring the use of the MIC for generating informative molecular fingerprints from rare populations of oncology samples -- for example, tumor stem cells."

The research, which appears in the Aug. 1 issue of the journal Cancer Research, represents the teamwork of 35 co-authors from UCLA's Jonsson Comprehensive Cancer Center with expertise in surgery, pathology, cancer biology, bioinformatics and diagnostic devices.

Led by Tseng and Thomas Graeber, an assistant professor of molecular and medical pharmacology, both of whom are researchers at the Crump Institute for Molecular Imaging at the David Geffen School of Medicine at UCLA and the California NanoSystems Institute (CNSI) at UCLA, the team analyzed a panel of 19 human brain tumor biopsies to show the clinical application of the MIC platform to solid tumors.

The researchers also developed new bioinformatics -- computational and statistical techniques and algorithms -- that allowed them to process and analyze the data gleaned from the MIC platform's single-cell measurements.

"Because the measurements are at the single-cell level, computational algorithms are then used to organize and find patterns in the thousands of measurements," Graeber said. "These patterns relate to the growth signaling pathways active in the tumor that should be targeted in genetically informed or personalized anticancer therapies."

"The single-cell nature of the MIC brain tumor data presented an exciting and challenging opportunity," said Dr. Nicholas Graham, a postdoctoral scholar at the CNSI who worked out the data analysis. "To make sense of the data, we had to develop some new bioinformatics approaches that would preserve the power of single-cell analysis but allow for comparison between patients."

Molecular and medical pharmacology graduate researcher Michael Masterman-Smith approached the project as a translational cancer biologist.

"When we incorporated patient outcome data into our analyses and found that these 'biosignatures' clustered to reveal distinctive signaling phenomena that correlated with outcome, it got truly exciting," he said.

Microscale technology platforms are finding wide application in biological assays in which careful manipulation and measurement of limited sample amounts are required, and the new MIC platform is capable of making molecular measurements on small tumor samples provided by tumor resection and biopsy using as few as 1,000 to 3,000 cells, according to the researchers.

"The promise and attractiveness of this approach is the small amount of tissue needed for analysis in the face of increasing numbers of prognostic and predictive markers, and the possibility of quantifying tumor genetic heterogeneity," said Dr. William Yong, a Jonsson Cancer Center physician-scientist who led the pathology aspects of the research. "However, much work remains to validate this study with larger sample sizes and with more markers."

"We are excited about the possibility of using this method to investigate responses of individual tumors to potential therapeutics, as well as to enhance our knowledge about how they become resistant to therapies," said Dr. Harley Kornblum, a physician-scientist who studies brain tumor biology and is a member of both UCLA's Intellectual and Developmental Disabilities Research Center and the Johnson Cancer Center cell biology program area.

"Scientific, medical and engineering disciplines each have their own approach to problem-solving" said Dr. Jing Sun, a postdoctoral scholar at CNSI and an organic chemist. "For the innovative process to yield something useful, it must be faster, better, cheaper and -- of course, with microscale technologies -- smaller."

The researchers will next apply the new platform to larger cohorts of cancer patient samples and integrate the diagnostic approach into clinical trials of molecular therapies.

CytoScale Diagnostics has signed a letter of agreement regarding the technology mentioned in this paper.

This study was funded by the National Cancer Institute/ National Institutes of Health (NCI/NIH) and the National Institute of Neurological Disorders and Stroke (NINDS).


Story Source:

The above story is based on materials provided by University of California - Los Angeles. The original article was written by Jennifer Marcus. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jing Sun, Michael D. Masterman-Smith, Nicholas A. Graham, Jing Jiao, Jack Mottahedeh, Dan R. Laks, Minori Ohashi, Jason Dejesus, Ken-Ichiro Kamei, Ki-Bum Lee, Hao Wang, Zeta T.f. Yu, Yi-Tsung Lu, Shuang Hou, Keyu Li, Max Liu, Nangang Zhang, Shutao Wang, Brigitte Angenieux, Eduard Panosyan, Eric R. Samuels, Jun Park, Dirk Williams, Vera Konkankit, David Nathanson, R. Michael Van Dam, Michael E. Phelps, Hong Wu, Linda M. Liau, Paul S. Mischel, Jorge A. Lazareff, Harley I. Kornblum, William H. Yong, Thomas G. Graeber, and Hsian-Rong Tseng. a Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens. Cancer Res, August 1, 2010; 70:6128-6138; Published Online July 14, 2010 DOI: 10.1158/0008-5472.CAN-10-0076

Cite This Page:

University of California - Los Angeles. "New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors." ScienceDaily. ScienceDaily, 4 August 2010. <www.sciencedaily.com/releases/2010/08/100803101926.htm>.
University of California - Los Angeles. (2010, August 4). New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/08/100803101926.htm
University of California - Los Angeles. "New diagnostic chip able to generate single-cell molecular 'fingerprints' for brain tumors." ScienceDaily. www.sciencedaily.com/releases/2010/08/100803101926.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins